Ganeden introduces immune support ingredient

Staimune developed using GanedenBC30

September 15, 2017

Developed using its patented probiotic strain GanedenBC30, Ganeden announced a new immune health ingredient: Staimune. The new ingredient utilizes the cells of GanedenBC30 probiotics to support immune health at cost-effective inclusion levels, the company says. Officially identified as Inactivated Bacillus coagulans GBI-30, 6086, Staimune’s ease of formulation opens up new opportunities in functional foods and beverages — most notably in shelf-stable beverages and high-water-activity products, it says. Staimune is Food and Drug Administration generally recognized as safe, non-GMO, organic compliant and kosher. With an inclusion rate of 50 mg, Staimune does not alter the flavor or texture profiles of finished goods, it adds.

Ganeden Inc., 5800 Landerbrook Drive, Suite 300, Mayfield Heights, Ohio 44124; 440/229-5200; ganedenprobiotics.com.

You must login or register in order to post a comment.

In light of the widespread use of rPET in the beverage market, the quality control of preforms is a useful activity that is experiencing increasing importance today. Together with the players of this market, we think the purpose of controls isn't just to detect defects but their prevention through process correction.

This webinar will focus on the benefits of implementing a true data infrastructure, and the challenges that organizations will face along this journey.